| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | procentriole | 7.05e-05 | 3 | 102 | 2 | GO:0120098 | |
| GeneOntologyCellularComponent | anchoring junction | FLT1 SORBS2 RTN4 TRPC6 SORBS1 ACTN1 TRIM29 ITGB4 CDH22 LMO7 TJP1 SVIL NECTIN4 WNK3 PDZD2 | 7.62e-05 | 976 | 102 | 15 | GO:0070161 |
| GeneOntologyCellularComponent | adherens junction | 8.17e-05 | 212 | 102 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | pericentriolar material | 3.38e-04 | 28 | 102 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | procentriole replication complex | 3.49e-04 | 6 | 102 | 2 | GO:0120099 | |
| GeneOntologyCellularComponent | cell-cell junction | TRPC6 SORBS1 ACTN1 TRIM29 CDH22 LMO7 TJP1 NECTIN4 WNK3 PDZD2 | 6.25e-04 | 591 | 102 | 10 | GO:0005911 |
| Domain | SOHO | 8.15e-05 | 3 | 98 | 2 | PS50831 | |
| Domain | Sorb | 8.15e-05 | 3 | 98 | 2 | SM00459 | |
| Domain | Sorb | 8.15e-05 | 3 | 98 | 2 | PF02208 | |
| Domain | SoHo_dom | 8.15e-05 | 3 | 98 | 2 | IPR003127 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 3.23e-06 | 73 | 79 | 6 | M638 | |
| Pubmed | CEP85 FOS PSMA2 PSMB4 PHF6 ZC3H18 CEP192 UPF1 CREBBP NUP205 PRDM1 NFIA RFXANK SVIL RLIM NCOA1 CEP152 FOXC1 | 1.71e-07 | 1429 | 102 | 18 | 35140242 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SORBS2 SPIRE1 SORBS1 CEP192 TMCC3 SLC38A2 SBF1 LMO7 TJP1 SVIL NAV2 CEP152 IRS2 WNK3 | 2.32e-07 | 861 | 102 | 14 | 36931259 |
| Pubmed | 4.87e-07 | 6 | 102 | 3 | 10497212 | ||
| Pubmed | SORBS2 CEP85 PPP1R9A SORBS1 CEP192 LMO7 TJP1 CEP152 IRS2 PRKDC | 8.10e-07 | 446 | 102 | 10 | 24255178 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 1.39e-06 | 118 | 102 | 6 | 27377895 | |
| Pubmed | 2.03e-06 | 9 | 102 | 3 | 22387553 | ||
| Pubmed | 2.44e-06 | 130 | 102 | 6 | 12421765 | ||
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 3.28e-06 | 77 | 102 | 5 | 24927568 | |
| Pubmed | 3.71e-06 | 529 | 102 | 10 | 14621295 | ||
| Pubmed | FOS RTN4 FOXJ3 CREBBP HOXA1 MEOX2 HOXB5 NFIA LMO7 NCOA1 PLXNA1 | 7.76e-06 | 709 | 102 | 11 | 22988430 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 31908000 | ||
| Pubmed | Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac. | 8.52e-06 | 2 | 102 | 2 | 11326277 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 30056265 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 9126963 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28377452 | ||
| Pubmed | Protein kinase WNK3 regulates the neuronal splicing factor Fox-1. | 8.52e-06 | 2 | 102 | 2 | 23027929 | |
| Pubmed | Cardiovascular adaptations of pregnancy in T and B cell-deficient mice. | 8.52e-06 | 2 | 102 | 2 | 21613629 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 21602176 | ||
| Pubmed | Dendritic cells require T cells for functional maturation in vivo. | 8.52e-06 | 2 | 102 | 2 | 10591187 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 23203926 | ||
| Pubmed | c-fos overexpression in splenic B cells augments development of marginal zone B cells. | 8.52e-06 | 2 | 102 | 2 | 15607821 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 1661315 | ||
| Pubmed | Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS. | 8.52e-06 | 2 | 102 | 2 | 38063270 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 35339471 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 25429109 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28970258 | ||
| Pubmed | ELOA CEP85 LEMD3 PPP1R9A CEP192 CACHD1 PHKA1 SBF1 TJP1 SVIL DUSP10 NBR1 FOXC1 | 1.24e-05 | 1049 | 102 | 13 | 27880917 | |
| Pubmed | 1.33e-05 | 16 | 102 | 3 | 26968737 | ||
| Pubmed | 1.43e-05 | 371 | 102 | 8 | 15747579 | ||
| Pubmed | 1.63e-05 | 378 | 102 | 8 | 34315543 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.79e-05 | 184 | 102 | 6 | 32908313 | |
| Pubmed | 2.20e-05 | 191 | 102 | 6 | 24146773 | ||
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 2.48e-05 | 195 | 102 | 6 | 17110338 | |
| Pubmed | Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. | 2.55e-05 | 3 | 102 | 2 | 14676194 | |
| Pubmed | Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection. | 2.55e-05 | 3 | 102 | 2 | 22665378 | |
| Pubmed | Cereblon inhibits proteasome activity by binding to the 20S core proteasome subunit beta type 4. | 2.55e-05 | 3 | 102 | 2 | 23026050 | |
| Pubmed | Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. | 2.55e-05 | 3 | 102 | 2 | 10524622 | |
| Pubmed | Human Cep192 and Cep152 cooperate in Plk4 recruitment and centriole duplication. | 2.55e-05 | 3 | 102 | 2 | 23641073 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 10848596 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 26493679 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 12510380 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 27197263 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11713256 | ||
| Pubmed | Reversal of malignant ADAR1 splice isoform switching with Rebecsinib. | 2.55e-05 | 3 | 102 | 2 | 36803553 | |
| Pubmed | The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. | 2.55e-05 | 3 | 102 | 2 | 10487758 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 9642216 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 37729060 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 16125169 | ||
| Pubmed | Transcriptional activation by STAT6 requires the direct interaction with NCoA-1. | 2.55e-05 | 3 | 102 | 2 | 11574547 | |
| Pubmed | The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. | 2.55e-05 | 3 | 102 | 2 | 8885865 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 10545405 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 12559174 | ||
| Pubmed | LMO7 Is a Negative Feedback Regulator of Transforming Growth Factor β Signaling and Fibrosis. | 2.55e-05 | 3 | 102 | 2 | 30586711 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 10085123 | ||
| Pubmed | HOXB5 cooperates with NKX2-1 in the transcription of human RET. | 2.55e-05 | 3 | 102 | 2 | 21677782 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 29594927 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19194464 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 11178737 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 24277814 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 22937164 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 36490268 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 16520097 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 18725523 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 26779602 | ||
| Pubmed | V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. | 2.55e-05 | 3 | 102 | 2 | 8769647 | |
| Pubmed | B cell acute lymphoblastic leukemia cells mediate RANK-RANKL-dependent bone destruction. | 2.55e-05 | 3 | 102 | 2 | 32938796 | |
| Pubmed | Ablation of Ezh2 in neural crest cells leads to aberrant enteric nervous system development in mice. | 2.69e-05 | 20 | 102 | 3 | 30169530 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CEP85 LEMD3 PSMA2 RTN4 PSMB4 PUSL1 NUP205 SBF1 TJP1 IRS2 DUSP10 PRKDC | 2.91e-05 | 974 | 102 | 12 | 28675297 |
| Pubmed | 3.00e-05 | 60 | 102 | 4 | 19075228 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 3.71e-05 | 552 | 102 | 9 | 10737800 | |
| Pubmed | 3.91e-05 | 128 | 102 | 5 | 23858473 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOS PSMB4 PUSL1 TRIM29 FOXJ3 CREBBP NUP205 FOXB1 NFIA NBR1 FOXC1 | 4.43e-05 | 857 | 102 | 11 | 25609649 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 4.44e-05 | 565 | 102 | 9 | 25468996 | |
| Pubmed | FOXC1 transcriptional regulatory activity is impaired by PBX1 in a filamin A-mediated manner. | 5.09e-05 | 4 | 102 | 2 | 15684392 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 10551785 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 23977053 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 23740949 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 10202929 | ||
| Pubmed | Anti-CD20 antibody therapy and susceptibility to Pneumocystis pneumonia. | 5.09e-05 | 4 | 102 | 2 | 25733518 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 12208951 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 17297445 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 17209045 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 11463834 | ||
| Pubmed | Early thymocyte development is regulated by modulation of E2A protein activity. | 5.09e-05 | 4 | 102 | 2 | 11560990 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 12884298 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 18395091 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 11113179 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 19000702 | ||
| Pubmed | Homeostatic regulation of intestinal villous epithelia by B lymphocytes. | 5.09e-05 | 4 | 102 | 2 | 11884426 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 18491294 | ||
| Pubmed | Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. | 5.09e-05 | 4 | 102 | 2 | 12438215 | |
| Pubmed | A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. | 5.09e-05 | 4 | 102 | 2 | 10339548 | |
| Pubmed | Interaction of U-box E3 ligase SNEV with PSMB4, the beta7 subunit of the 20 S proteasome. | 5.09e-05 | 4 | 102 | 2 | 15660529 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 27941793 | ||
| Pubmed | Activation of PPARgamma coactivator-1 through transcription factor docking. | 5.09e-05 | 4 | 102 | 2 | 10558993 | |
| Pubmed | Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates. | 5.09e-05 | 4 | 102 | 2 | 19362533 | |
| Pubmed | β4 Integrin signaling induces expansion of prostate tumor progenitors. | 5.09e-05 | 4 | 102 | 2 | 23348745 | |
| Pubmed | A signature motif in transcriptional co-activators mediates binding to nuclear receptors. | 5.09e-05 | 4 | 102 | 2 | 9192902 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 9556555 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 22648184 | ||
| Interaction | CNTRL interactions | 4.98e-06 | 193 | 99 | 8 | int:CNTRL | |
| Interaction | AFDN interactions | SORBS2 PPP1R9A SORBS1 CEP192 SOCS6 USP21 SLC38A2 TJP1 NECTIN4 CEP152 | 5.62e-06 | 333 | 99 | 10 | int:AFDN |
| Interaction | YWHAH interactions | SORBS2 SPIRE1 SORBS1 CEP192 SOCS6 CREBBP TMCC3 USP21 SLC38A2 SBF1 LMO7 TJP1 SVIL NAV2 NCOA1 CEP152 IRS2 WNK3 | 6.20e-06 | 1102 | 99 | 18 | int:YWHAH |
| Interaction | DYNLT5 interactions | 1.35e-05 | 10 | 99 | 3 | int:DYNLT5 | |
| Interaction | VASP interactions | 1.45e-05 | 294 | 99 | 9 | int:VASP | |
| Interaction | FBF1 interactions | 2.16e-05 | 171 | 99 | 7 | int:FBF1 | |
| Interaction | AMOT interactions | 2.33e-05 | 312 | 99 | 9 | int:AMOT | |
| Interaction | SFN interactions | SORBS2 SPIRE1 ZC3H18 SORBS1 CEP192 ACTN1 TMCC3 NFIA LMO7 TJP1 SVIL NAV2 IRS2 | 3.37e-05 | 692 | 99 | 13 | int:SFN |
| Interaction | ZYX interactions | 3.52e-05 | 329 | 99 | 9 | int:ZYX | |
| Interaction | NRXN1 interactions | 3.86e-05 | 127 | 99 | 6 | int:NRXN1 | |
| Interaction | LZTS2 interactions | ELOA SORBS2 CEP85 SORBS1 CEP192 TRIM29 FAM90A1 SBF1 TJP1 RBFOX1 CEP152 | 4.29e-05 | 512 | 99 | 11 | int:LZTS2 |
| Interaction | HOXD13 interactions | 5.23e-05 | 82 | 99 | 5 | int:HOXD13 | |
| Interaction | TERF1 interactions | 5.32e-05 | 347 | 99 | 9 | int:TERF1 | |
| Interaction | PBX1 interactions | 6.21e-05 | 85 | 99 | 5 | int:PBX1 | |
| Interaction | NFIC interactions | 7.99e-05 | 210 | 99 | 7 | int:NFIC | |
| Interaction | CDH1 interactions | RTN4 SORBS1 ACTN1 UPF1 TRIM29 CREBBP LMO7 TJP1 SVIL NAV2 NECTIN4 CRYBG1 PRKDC | 9.73e-05 | 768 | 99 | 13 | int:CDH1 |
| Interaction | YWHAQ interactions | SORBS2 SPIRE1 SORBS1 CEP192 UPF1 SOCS6 ITGB4 TMCC3 SBF1 LMO7 TJP1 SVIL NAV2 NCOA1 IRS2 PRKDC | 1.05e-04 | 1118 | 99 | 16 | int:YWHAQ |
| Interaction | ODF2 interactions | 1.30e-04 | 158 | 99 | 6 | int:ODF2 | |
| Interaction | ACTR3 interactions | 1.30e-04 | 305 | 99 | 8 | int:ACTR3 | |
| Interaction | ADAMTSL2 interactions | 1.42e-04 | 4 | 99 | 2 | int:ADAMTSL2 | |
| Interaction | VIM interactions | CEP85 PSMA2 ZC3H18 SORBS1 ACTN1 TRIM29 ITGB4 LMO7 TJP1 SVIL RLIM CRYBG1 PRKDC | 1.53e-04 | 804 | 99 | 13 | int:VIM |
| GeneFamily | Guanylate cyclase receptors | 3.71e-04 | 7 | 77 | 2 | 343 | |
| GeneFamily | Forkhead boxes | 8.11e-04 | 43 | 77 | 3 | 508 | |
| GeneFamily | HOXL subclass homeoboxes | 1.41e-03 | 52 | 77 | 3 | 518 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.34e-03 | 17 | 77 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.62e-03 | 18 | 77 | 2 | 91 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 9.11e-07 | 137 | 99 | 7 | M39241 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.95e-10 | 198 | 100 | 9 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.59e-10 | 200 | 100 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.07e-08 | 188 | 100 | 8 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.67e-08 | 199 | 100 | 8 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.74e-08 | 200 | 100 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.74e-08 | 200 | 100 | 8 | d014959891893b6d3854a471fba1dc50c6625a0a | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.36e-07 | 174 | 100 | 7 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-07 | 181 | 100 | 7 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.77e-07 | 181 | 100 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.84e-07 | 182 | 100 | 7 | d4cb23b5a974c096a0ce84b47fe351eef44894d7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.21e-07 | 187 | 100 | 7 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.84e-07 | 194 | 100 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-07 | 196 | 100 | 7 | 3e99a367b7d817e1f1221450fcec20ad7a7c7a2a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-07 | 196 | 100 | 7 | 1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31 | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.15e-07 | 197 | 100 | 7 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.15e-07 | 197 | 100 | 7 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.15e-07 | 197 | 100 | 7 | b1135378d768fbbe62a75747d1e8653d35252187 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.15e-07 | 197 | 100 | 7 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.37e-07 | 199 | 100 | 7 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | NS-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.37e-07 | 199 | 100 | 7 | d64adb68502be596ce55fb2cb63fe1cfa2c5f8ba | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.37e-07 | 199 | 100 | 7 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.37e-07 | 199 | 100 | 7 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | control-Epithelial|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.48e-07 | 200 | 100 | 7 | f95bbb94e51ac28b1995026c599ec3a34e012916 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.48e-07 | 200 | 100 | 7 | 8c1d4fffa5abe89ee2ff84fed2dfa97c779bde04 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.48e-07 | 200 | 100 | 7 | 1026b4ede4ea61d01ea942164b37a08c8c8234ff | |
| ToppCell | Severe-Epithelial-Epithelial-|Severe / Condition, Lineage, Cell class and cell subclass | 3.48e-07 | 200 | 100 | 7 | 8669ce08f93eefb8ac970e30cdc4b1f908023c54 | |
| ToppCell | Severe-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 3.48e-07 | 200 | 100 | 7 | 6ead9db88568bb829d564a6d8e85f71fd765bac0 | |
| ToppCell | Severe-Epithelial-Epithelial|Severe / Condition, Lineage, Cell class and cell subclass | 3.48e-07 | 200 | 100 | 7 | 3bd1ce2793651c9badd69f011d2531183594e5f4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-LGR5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.48e-07 | 200 | 100 | 7 | 72c9cd872074b60f62685a95eab83c41e609eb6e | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.21e-06 | 168 | 100 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.89e-06 | 176 | 100 | 6 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-06 | 178 | 100 | 6 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | COPD-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.40e-06 | 181 | 100 | 6 | 6d8a886b4afe729f8a05b9c0f4ea9375de735da4 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.51e-06 | 182 | 100 | 6 | 37547b36264090b49a193a8ef3a8d88e647f0b79 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.51e-06 | 182 | 100 | 6 | 3fddadb2ff75013ec6eeb415872667a6bae1da2d | |
| ToppCell | COPD-Epithelial-Basal|COPD / Disease state, Lineage and Cell class | 3.62e-06 | 183 | 100 | 6 | 0f760e393edc91009bf6c7e02eeac039a1dfb4ed | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 3.74e-06 | 184 | 100 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-06 | 185 | 100 | 6 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-06 | 186 | 100 | 6 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 3.98e-06 | 186 | 100 | 6 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.10e-06 | 187 | 100 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-06 | 188 | 100 | 6 | 8671fdbc4138e6f9559920779c98628ed80f0da3 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 4.36e-06 | 189 | 100 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 190 | 100 | 6 | da2fcd4a2cc6e45c8174109d892f1424e39919a1 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 190 | 100 | 6 | d3e46cf800a07ca9b01c78192962d223b9785d05 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 190 | 100 | 6 | 3395b2ff6ffadf84cdb1b5a37a5b6be05b56c30f | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 190 | 100 | 6 | dd89ef1ecea20b2f6fbdc6cea4ca41b28b3ed822 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 190 | 100 | 6 | c8370c922e0cf0e0c36e02e1ed2b4053ad6a8073 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 190 | 100 | 6 | e584eaccbc22aa7f7a4340ed8a2a8b45ddca93f4 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 190 | 100 | 6 | 5174f91a880f85bb20806023aa68bd4b8ca24ea5 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.49e-06 | 190 | 100 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 190 | 100 | 6 | 90e494cbfbed33a3a0d29bb7dae83f0c81580bcf | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 4.63e-06 | 191 | 100 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 4.77e-06 | 192 | 100 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 4.77e-06 | 192 | 100 | 6 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 4.77e-06 | 192 | 100 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-06 | 193 | 100 | 6 | 54024a373e42e1c0bcc327dc084564b83b63a9d4 | |
| ToppCell | droplet-Fat-Mat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-06 | 193 | 100 | 6 | 81d908594d2983ba7e7c1ec25afdde4315d9690e | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.92e-06 | 193 | 100 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.92e-06 | 193 | 100 | 6 | 3316d6a39abb6a518d45b846254325fc7a8b2035 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.92e-06 | 193 | 100 | 6 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 5.06e-06 | 194 | 100 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.06e-06 | 194 | 100 | 6 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.06e-06 | 194 | 100 | 6 | aaecde88bd54134a938e76cdf059c1c2653e4e77 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.22e-06 | 195 | 100 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.22e-06 | 195 | 100 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 5.22e-06 | 195 | 100 | 6 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.22e-06 | 195 | 100 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | facs-GAT-Fat-3m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 196 | 100 | 6 | b6cc1f466d45479764080d34b1daeb8243a5a9f3 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 196 | 100 | 6 | ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 196 | 100 | 6 | 039044ab28c53391c34d8226fb8cf78549e63ef4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 196 | 100 | 6 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 196 | 100 | 6 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | P07-Mesenchymal-myocytic_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.53e-06 | 197 | 100 | 6 | 378299fe2ec6ed2fc858febb78ff1ac0898e457d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 197 | 100 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-06 | 197 | 100 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.53e-06 | 197 | 100 | 6 | 1a6b2ca94a4634c24cd95481576c955b20000a5f | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.53e-06 | 197 | 100 | 6 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.69e-06 | 198 | 100 | 6 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.69e-06 | 198 | 100 | 6 | 637f11e292b90d86cdc0d0d828eb26f38289c25b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.69e-06 | 198 | 100 | 6 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.69e-06 | 198 | 100 | 6 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.69e-06 | 198 | 100 | 6 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.69e-06 | 198 | 100 | 6 | c9c96066c7fa897b583657f0b77ea093920ae9ba | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.69e-06 | 198 | 100 | 6 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.69e-06 | 198 | 100 | 6 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.86e-06 | 199 | 100 | 6 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.86e-06 | 199 | 100 | 6 | aacd3ffa40a6e6f435aa9be5b959d88812eb69d4 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.86e-06 | 199 | 100 | 6 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| ToppCell | 18-Distal-Mesenchymal|Distal / Age, Tissue, Lineage and Cell class | 5.86e-06 | 199 | 100 | 6 | d65150d2e24c40aa82712e7f034f6772102bd293 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.03e-06 | 200 | 100 | 6 | f386a86b127433cbac306950443355bd723080ff | |
| ToppCell | NS-moderate-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.03e-06 | 200 | 100 | 6 | 85940b4bf7971b872469dea8b8d7a45bdeb2a909 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.03e-06 | 200 | 100 | 6 | 1c02a7f4047d1d2208cc522c6bb4a4989d7845bb | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.03e-06 | 200 | 100 | 6 | 0cc7ff7b6a4eb05d2370ec2f3b9dbfe8cb0699de | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.03e-06 | 200 | 100 | 6 | b75154417c215b8853186bff46d624ebd387ac4f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.03e-06 | 200 | 100 | 6 | b9cede2e0939c6b60ce1aa16d7efaaae79354580 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.03e-06 | 200 | 100 | 6 | b762bf6f432eac05a476f6e2ab4da27dd13a2317 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.03e-06 | 200 | 100 | 6 | 4c63204e0d868dd4c11c1604a238624a3ad54485 | |
| ToppCell | Severe_COVID-19-Epithelial|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.03e-06 | 200 | 100 | 6 | 49910efb6d888c208cd50530b03af19f87070630 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.03e-06 | 200 | 100 | 6 | 03051d2190244208905e1611019d4b8fd200bae0 | |
| Disease | severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, Nk cell-positive (implicated_via_orthology) | 1.05e-05 | 2 | 96 | 2 | DOID:0090013 (implicated_via_orthology) | |
| Disease | severe combined immunodeficiency (implicated_via_orthology) | 3.14e-05 | 3 | 96 | 2 | DOID:627 (implicated_via_orthology) | |
| Disease | Transitional cell carcinoma of bladder | 6.26e-05 | 4 | 96 | 2 | C0279680 | |
| Disease | age at assessment, pelvic organ prolapse | 3.75e-04 | 43 | 96 | 3 | EFO_0004710, EFO_0008007 | |
| Disease | peptide measurement | 4.51e-04 | 109 | 96 | 4 | EFO_0010520 | |
| Disease | immature platelet fraction | 5.34e-04 | 114 | 96 | 4 | EFO_0009187 | |
| Disease | immature platelet measurement | 6.28e-04 | 119 | 96 | 4 | EFO_0803541 | |
| Disease | susceptibility to rubella infection measurement | 6.57e-04 | 52 | 96 | 3 | EFO_0008418 | |
| Disease | Metastatic melanoma | 7.34e-04 | 54 | 96 | 3 | C0278883 | |
| Disease | Astigmatism | 8.49e-04 | 129 | 96 | 4 | HP_0000483 | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 9.29e-04 | 14 | 96 | 2 | DOID:627 (is_implicated_in) | |
| Disease | myocardial infarction | 1.01e-03 | 350 | 96 | 6 | EFO_0000612 | |
| Disease | response to opioid | 1.05e-03 | 61 | 96 | 3 | EFO_0008541 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.22e-03 | 16 | 96 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.22e-03 | 16 | 96 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.22e-03 | 16 | 96 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.22e-03 | 16 | 96 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.22e-03 | 16 | 96 | 2 | C0025237 | |
| Disease | Van Buchem disease | 1.38e-03 | 17 | 96 | 2 | C0432272 | |
| Disease | age at onset, Myopia | 1.48e-03 | 150 | 96 | 4 | EFO_0004847, HP_0000545 | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.56e-03 | 670 | 96 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | Osteochondrodysplasias | 1.73e-03 | 19 | 96 | 2 | C0029422 | |
| Disease | Dyschondroplasias | 1.73e-03 | 19 | 96 | 2 | C0013366 | |
| Disease | Multiple Epiphyseal Dysplasia | 1.92e-03 | 20 | 96 | 2 | C0026760 | |
| Disease | Severe Combined Immunodeficiency | 1.92e-03 | 20 | 96 | 2 | C0085110 | |
| Disease | pars triangularis volume measurement | 1.92e-03 | 20 | 96 | 2 | EFO_0010321 | |
| Disease | Renal glomerular disease | 2.53e-03 | 23 | 96 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.53e-03 | 23 | 96 | 2 | C4521256 | |
| Disease | QRS duration | 2.94e-03 | 298 | 96 | 5 | EFO_0005055 | |
| Disease | blood rubidium measurement | 3.24e-03 | 26 | 96 | 2 | EFO_0021529 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MASSSTVPLGFHYET | 1 | Q9BXK5 | |
| FSPSGYLSDTEESNM | 1611 | O94986 | |
| DSVPGALDYMSFSTA | 871 | P12814 | |
| SDMPYRAAALSATSA | 311 | Q13939 | |
| GDPAMISSDTSYLSS | 51 | Q96QU6 | |
| EMSPSKNSFISYSRG | 1276 | Q8IZF6 | |
| SYSRGTPSLEMTDTG | 1286 | Q8IZF6 | |
| SSRPMYGAVTSFLHS | 156 | Q9UKT5 | |
| DSGEMSESFPYRTKA | 1381 | Q92793 | |
| MLSAGSFSSPYEHLS | 656 | Q5VU97 | |
| PDSSYGSSFFTMDLN | 146 | Q86UQ4 | |
| DLGLDYYSGDSSMSP | 1311 | Q5TGY3 | |
| LSDLESSSYYSMSPG | 246 | Q12857 | |
| FGGRSYMPSTHRTTE | 156 | P55895 | |
| ELSYPMISAGSFGLS | 136 | P25092 | |
| STPDSFMDPASALYR | 26 | P28070 | |
| TSGPTMRYLRTSQDF | 1076 | Q92621 | |
| EVSPTGSFSAHYLSM | 461 | Q9Y2U8 | |
| LTPYTTFGAGDMASR | 721 | Q8NFP4 | |
| STESSDYLRVASGPM | 136 | A8MXZ1 | |
| LSSSLEPSYAEGSQM | 1731 | Q8WXI7 | |
| SSFYPSAEGRAMSKT | 441 | Q6TGC4 | |
| LDIAPRYSSFLMGAS | 341 | O00476 | |
| ARSVPDMDLSGSFYA | 286 | P01100 | |
| ATYMLDPARGSFLSA | 416 | Q02846 | |
| ARFSIPSMTEDYAGR | 81 | Q8NHJ6 | |
| STESSDYLRVASGPM | 136 | Q86YD7 | |
| TLLYDSAPSGRFGTM | 1186 | P46020 | |
| QSSSYLDDSSPTGLM | 531 | Q8WYA1 | |
| ANLTYMPSSSGSARS | 56 | Q9Y6W6 | |
| STESSDYLRVASGPM | 136 | A8MWA6 | |
| SRYESMLRTASSPDS | 1621 | Q9UIW2 | |
| PSLSSMYGDAEDSSS | 1546 | O15018 | |
| DYSDVDSFTGSPVSM | 81 | Q8N687 | |
| TRGISSLPRSYTMDD | 921 | Q8WWI1 | |
| KMLSPGFDSSVYSDL | 651 | Q86TH1 | |
| GRSDHMSYPELSTSS | 31 | P50222 | |
| MNSFLEYPILSSGDS | 6 | P49639 | |
| FMYLRPSSSYALDTD | 261 | Q8NGR4 | |
| EDGIMSGYRRPTSSA | 21 | Q6TCH4 | |
| FLMYSDDVLRSPSGS | 1346 | P16144 | |
| DSATPISMASGDYSA | 226 | Q99853 | |
| SSMPRYADASGRNTL | 1251 | O95248 | |
| SGSSLSGSYRDPAAM | 26 | P09067 | |
| DEYTLMRATFSGSAG | 596 | Q9Y4H2 | |
| SVYDRSSQGRPSSMY | 956 | Q92900 | |
| GPGFASTDISMYTLS | 296 | Q8WXS5 | |
| TSPEAVSGYSFAMAA | 496 | Q9P2D3 | |
| TTGLFLAMHYSPDAS | 46 | P00156 | |
| RMSPTYSSDPESSDY | 186 | Q14241 | |
| MAFPSSQSLYRTSGA | 531 | Q12948 | |
| RASTPYSIDSDSLGM | 176 | Q9UPW0 | |
| YMGSTSPSRHFSSLD | 171 | O75417 | |
| SPGLSRDLMYFSGAT | 141 | Q6P2H3 | |
| FSDEPRTMFSLDTYS | 286 | P12111 | |
| FYHPSLLGSMDSTTA | 316 | Q9NY43 | |
| DSRRYTDGMLPFSSG | 316 | Q8TEP8 | |
| YSFETMAPTGLSSLT | 46 | Q9BZJ6 | |
| MASDADDPTYGSSAR | 191 | Q9UJ99 | |
| PLDFSSLMSSEYESR | 2126 | Q8NDH2 | |
| TDFMGLFKSSRYDPS | 981 | Q9Y4K1 | |
| RYDPSISFSGMSLSD | 991 | Q9Y4K1 | |
| STESSDYLRVARGPM | 136 | A6NIJ5 | |
| STESSDYLRVASGPM | 136 | P0C7X0 | |
| LTTEADSGYTPMDLA | 216 | O14593 | |
| LSPSGKTTDYAFEMA | 36 | Q8IWW8 | |
| TMSYRSDSDIFTPYG | 156 | P21217 | |
| MSSAPASGSVRARYL | 1 | Q8N0Z8 | |
| EYSEMGSSFSVSPKA | 296 | Q9NQC3 | |
| EGSSMYSAPSSLVYT | 236 | Q9NWB1 | |
| SSSFSLKGYPSLMRS | 536 | Q14134 | |
| NMSPDTLALFSETAY | 756 | P0C7P3 | |
| MPGSDTALTVDRTYS | 1 | Q9ULS5 | |
| RDASSLYPGTETMGL | 161 | O95425 | |
| MEGSSSYEVPSVAAA | 1 | Q9C0I9 | |
| IPDRFMGSSSGADRY | 81 | A0A075B6K6 | |
| DTSRPLGDSMYSSAL | 741 | Q14596 | |
| MGLPTLEFSDSYLDS | 1 | A6NI28 | |
| EVMTRGTASSPSYRF | 316 | Q15788 | |
| GETLRSTFPSYMAEG | 6 | Q96NG3 | |
| STESSDYLRVASGPM | 136 | A8MX19 | |
| PYTDSRFRNSSMSLD | 1601 | Q8IVL1 | |
| PLGVTTSDTSYSDMA | 6 | Q9C0A6 | |
| SSGCSLYESSDLPLM | 786 | O75626 | |
| EKESPGLSFLMSYTS | 466 | Q8N1H7 | |
| GLSFLMSYTSRSPGL | 471 | Q8N1H7 | |
| MSYTSRSPGLNLFDS | 476 | Q8N1H7 | |
| RESPRSYSSTLTDMG | 836 | O94875 | |
| LSSSSATERYPMFTL | 416 | Q86TL0 | |
| GTDEMESSSYRDRSP | 186 | Q8IWS0 | |
| SYGASMELLSARETF | 166 | Q7RTX0 | |
| ISARSSEPFYSDDKM | 186 | Q9UK80 | |
| MGRFSISPDEDSSSY | 6 | Q96QD8 | |
| LSMSYSFDLSDVTTP | 401 | Q08AE8 | |
| SMDTRSFSSDYTHLP | 1491 | Q9HCF6 | |
| EMPCAFRASGATSYS | 46 | A6NLU5 | |
| LSYFMYSDSDSEPTG | 416 | Q9NVW2 | |
| DYMDLPFSSSPSRSA | 936 | Q9BX66 | |
| STDISDVSRSMFLYP | 6 | A2RTY3 | |
| MAERGYSFSLTTFSP | 1 | P25787 | |
| GSMDDRPSLSARDYV | 231 | Q2NKQ1 | |
| GPSYMSSLSYLADST | 2021 | P78527 | |
| SYSSSGARRPSLDSM | 686 | P07949 | |
| PGSEYSMYSTDSRHT | 826 | Q07157 | |
| NRGPAYMFSDRSTSL | 81 | Q9Y210 | |
| DYQGDSSTLLASPML | 1241 | P17948 | |
| GSRSYCLDSSSPMEV | 236 | O14544 | |
| MYADLASPVSSASSR | 731 | Q86VM9 | |
| SLFYSPSSPMSSDDE | 1511 | Q9BYP7 | |
| TEGPYDSLDYMTTTR | 1286 | Q9NR99 | |
| SERISRFDTMYDGPS | 121 | Q9ULJ8 | |
| MSEEPEGRSYSTLTT | 436 | Q96NY8 |